FDA approves Abbott's Omnilink Elite next-gen stent system

Tue, 08/07/2012 - 5:13pm
Mass Device

Abbott wins FDA approval for its next-generation Omnilink Elite balloon-expandable peripheral stent.

Abbott logo

Abbott (NYSE:ABT) won FDA approval for the latest in its line of peripheral vascular intervention devices, the Omnilink Elite balloon-expandable stent system.

The Omnilink Elite won indication for treatment of atherosclerotic iliac artery lesions, a condition that affects the lower extremities and can result in chronic pain, difficulty with walking and may lead to permanent disability, according to a press release.

The new stent system is based on the design of Abbott's Multi-Link coronary stents, but is made with a cobalt-chromium alloy that is stronger than stainless steel and more easily visible in imaging, according to the company.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.